XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Adjustments
Class A and B common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Accumulated deficit
Adjustments
Noncontrolling interests
Common Stock Including Additional Paid in Capital
Beginning balance (in shares) at Dec. 31, 2022     600,060            
Beginning balance at Dec. 31, 2022 $ 17,251,355 $ 30,511   $ 18,314,681 $ (523,090) $ (568,712) $ 30,511 $ 28,476  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 95,828         98,316   (2,488)  
Shares issued in connection with employee stock plans (in shares)     3,333            
Shares issued in connection with employee stock plans 6,825     6,825          
Change in other comprehensive loss (49,471)       (49,471)        
Share-based compensation 285,502     285,502          
Ending balance (in shares) at Mar. 31, 2023     603,393            
Ending balance at Mar. 31, 2023 17,620,550     18,607,008 (572,561) (439,885)   25,988  
Beginning balance (in shares) at Dec. 31, 2023     615,821            
Beginning balance at Dec. 31, 2023 18,692,836     19,601,992 (378,307) (528,429)   (2,420)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 470,820         472,005   (1,185)  
Shares issued in connection with employee stock plans (in shares)     4,806            
Shares issued in connection with employee stock plans 19,943     19,943          
Repurchases of common stock (in shares)     (3,563)            
Repurchases of common stock (252,095)   $ (252,100)           $ (252,095)
Change in other comprehensive loss (281,896)       (281,896)        
Share-based compensation 317,588     317,588          
Ending balance (in shares) at Mar. 31, 2024     617,064            
Ending balance at Mar. 31, 2024 $ 18,967,196     $ 19,687,428 $ (660,203) $ (56,424)   $ (3,605)